On Saturday, December 4, 2021, starting at 10:00 p.m. EST we will be launching the New FAST Graphs. This may cause temporary interruptions. We are sorry for any inconvenience this may cause.

BMY

Clorox (CLX) and Church & Dwight (CHD) versus Amgen (AMGN) and Bristol-Myers Squibb (BMY)

2021-10-21

Research Articles

4 Sagging Dividend Growth Stocks 2 Are Buys 2 Are Not Clorox, Church & Dwight, Amgen, Bristol-Myers Many high-quality dividend growth stocks have recently experienced substantial drops in their prices. When the price of a common stock drops, investors will almost assuredly ask me if I like it better now. In fact, it is one […]

Building A Dividend Growth Portfolio from Scratch in Today’s Expensive Market

2021-03-17

Research Articles

Introduction Building A Dividend Growth Portfolio Before we talk about a dividend growth portfolio, the stock market as measured by the S&P 500 is at an all-time high. However, that is not what concerns me. What I am worried about is the extremely high relative valuation of the market. To be clear, the market can […]

FAST Graphs Analyze out Loud Video Bristol-Myers Squibb

2020-05-06

Research Articles

Introduction Many of you, if you follow Bristol-Myers Squibb, all know that they recently merged with Celgene and they’ve now become a much bigger company.  What’s been happening in big pharma, even the big names like Merck and Pfizer, these were very strong growth stocks years ago, but in more recent times their growth has […]

Subscriber Request Series: Celgene Corp (NAS:CELG) and Bristol Myers (NYS:BMY)

2019-07-11

Research Articles

FAST Graphs Analyze Out Loud Celgene Corp $CELG: Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and […]

6 High Yield Pharmaceutical Companies: Do They Justify the Risk?

2011-01-12

Research Articles

Introduction Today Investors are keenly focused on income while simultaneously very risk averse.This current behavior brings with it a level of frustration.The appetite for yield is high precisely at a time when yields on the traditionally safest investments like bonds and CDs, etc. are at historic lows.On the other hand, dividend yields on many blue-chip […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.